Gian Life Care share price
BSE: 542918Healthcare ServicesSmall Cap
Gian Life Care Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2020
Last close ₹4.24up ₹0.04 (0.95%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹4.20.
29 Oct: open ₹4.34, high ₹4.34, low ₹4.07
52-week range of traded prices to 29 Oct 2026
₹3.93Low, 28 Oct 2026₹13.23High, 12 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4.38 Cr4,811th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,531
Results
Standalone, as consolidated accounts are on record for only 4 of the last ten years; ₹ crore.Gian Life Care quarterly results
Quarter to Dec 2025, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.12 Crup 70.12%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- ₹0.12 CrQuarter to Sep 2025: −₹0.46 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 10.9%
Revenue by quarter
Peak revenue ₹4.60 Cr, quarter to Mar 2024; lowest ₹0.66 Cr, quarter to Sep 2025
Net profit by quarter, a loss in red
- Net profit
- Loss
Back to profit in the quarter to Dec 2025, ₹0.12 CrA loss in 2 of the 8 quarters shown
| ₹ crore | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.60 | 1.98 | 1.95 | 1.59 | 1.11 | 0.87 | 0.66 | 1.12 |
| Net profit | 2.20 | 0.11 | 0.14 | 0.39 | −0.48 | 0.05 | −0.46 | 0.12 |
| Net margin | 47.8% | 5.4% | 7.3% | 24.3% | −42.8% | 6.3% | −70.0% | 10.9% |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2025, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹6.63 Crdown 49.46%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.16 Crdown 96.39%
- Net margin
- 2.3%
Revenue by year
Peak revenue ₹16 Cr, year to Mar 2022; lowest ₹6.63 Cr, year to Mar 2025
Net profit by year, a loss in red
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | 7.6 | 10.5 | 15.9 | 11.9 | 13.1 | 6.6 |
| Net profit | 1.1 | 2.0 | 4.4 | 1.3 | 4.3 | 0.2 |
| Net margin | 14.7% | 19.3% | 27.5% | 10.5% | 32.7% | 2.3% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2025 the company reports one business segment which carries all its revenue.
Where the return came from
Yearly rates to Mar 2025, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −29.8% | −96.4% | +1,845.3% | 0.0% |
| 3 years | −25.5% | −67.1% | +126.8% | 0.0% |
| 5 years | +23.4% | −32.7% | +83.5% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Gian Life Care competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Gian Life Care in market cap. 3 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Gian Life Care is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Dolphin Medical ServicesDOLPHMED | 10 | – | 1.02 | – | – | – | – | 0.00% |
 Family Care HospitalsFAMILYCARE | 10 | – | 1.05 | −93.9% | – | −73.4% | −27.5% | 0.00% |
 Dhanvantri Jeevan RekhaZDHJERK | 9 | – | 0.86 | +49.9% | – | – | 1.9% | 0.00% |
 Looks Health ServicesLOOKS | 8 | 334.69 | 0.54 | −5.1% | −69.0% | 0.2% | 0.2% | 0.00% |
 Boston Commerce531458 | 8 | – | – | – | – | – | – | 0.00% |
 Clinitech LaboratoryCTLLAB | 7 | 16.85 | 0.76 | – | – | 4.6% | – | 0.00% |
 Dr Lalchandani LabsDLCL | 6 | 94.53 | 0.42 | −6.0% | −84.8% | 0.5% | – | 0.00% |
 Ashram Online.comASHRAM | 5 | – | 0.49 | +26.0% | – | −1.0% | −2.7% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Gian Life Care announcements
Mar 2026
4 Mar · Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Approval To Enter Into Hospital Lab Management Services With M/S. Brahma Hospital (HUF)
Feb 2026
14 Feb · Results
9 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Jan 2026
Gian Life Care share price by year
Each calendar year to 2025.Gian Life Care share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 8.38 | −55.4% | 20.10 | 7.39 |
| 2024 | 18.80 | −5.3% | 25.51 | 18.31 |
| 2023 | 19.85 | −10.0% | 29.20 | 17.01 |
| 2022 | 22.05 | −39.1% | 63.16 | 16.75 |
| 2021 | 36.18 | +226.2% | 56.07 | 6.05 |
| 2020 | 11.09 | – | 13.18 | 5.93 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 27 Jan 2021. The 2020 close is its last trade, on 7 Sep 2020.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 28 Oct 2026 | 4.10 | 4.29 | 3.93 | 4.20 | 4.07 | 3,165 |
| 27 Oct 2026 | 4.32 | 4.34 | 4.02 | 4.09 | 4.05 | 2,634 |
| 26 Oct 2026 | 4.34 | 4.34 | 4.07 | 4.20 | 4.23 | 809 |
| 23 Oct 2026 | 4.26 | 4.26 | 4.05 | 4.20 | 4.07 | 6,984 |
| 22 Oct 2026 | 4.34 | 4.34 | 4.25 | 4.26 | 4.25 | 279 |
| 21 Oct 2026 | 4.21 | 4.54 | 4.14 | 4.15 | 4.20 | 9,702 |
| 19 Oct 2026 | 4.53 | 4.53 | 4.32 | 4.35 | 4.33 | 6,082 |
| 16 Oct 2026 | 4.64 | 4.64 | 4.31 | 4.54 | 4.45 | 5,133 |
| 15 Oct 2026 | 4.62 | 4.62 | 4.31 | 4.53 | 4.48 | 2,377 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus share history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 15 Nov 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company's board met on results that day or since the trading day before. Not adjusted for. |
| 29 Mar 2022 | Bonus | 0.4545 | Holders received 6 bonus shares for every 5 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout. Any other event is noted and not adjusted for.
Company details
- BSE code
- 542918
- ISIN
- INE063601012
- Industry
- Healthcare Services
- Website
- www.gianpathlabs.com
- CIN
- L85100UP2018PLC110119
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2018
- Registered office
- 7/216 (6), Swaroop Nagar, Kanpur 208002, Uttar Pradesh
- Share registrar
- Cameo Corporate Services Ltd
- Keeps the register of shareholders and handles transfers and dividend payments